A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line

A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line

<p>Abstract</p> <p>Background</p> <p>Although chronic myeloid leukemia (CML) treatment has improved since the introduction of imatinib mesylate (IM), cases of resistance have been reported. This resistance has been associated with the emergence of multidrug resistance (...

Full description

Bibliographic Details
Main Authors: Corrêa Stephany, Pizzatti Luciana, Du Rocher Bárbara, Mencalha André, Pinto Daniela, Abdelhay Eliana
Format: Article
Language:English
Published: BMC 2012-03-01
Series:Proteome Science
Subjects:
Imatinib mesylate
Chronic myeloid leukemia
LRPPRC
MCM7
Proteome
Mass spectrometry
Online Access:http://www.proteomesci.com/content/10/1/23

Internet

http://www.proteomesci.com/content/10/1/23

Similar Items